{
"NTRA": "Recent Zanzalintinib Developments",
"WOLF": "Deepening OpenAI Tie-Up And Unveiling New AI Tools",
"EMAT": "Deepening OpenAI Tie-Up And Unveiling New AI Tools",
"MGA": "2026 Outlook Tops Estimates",
"CRDO": "Surging AI Revenue Guidance And PCIe 6.0 Progress",
"RIVN": "Surging AI Revenue Guidance And PCIe 6.0 Progress",
"BFAM": "Strong Back-Up Care Growth and Center Rationalization",
"ETH-USD": "Challenging Industry Dynamics",
"MSTR": "Challenging Industry Dynamics",
"ELMD": "Record Revenue and Strategic Growth",
"PRAX": "Raising Target",
"INOD": "Sharp Recent Share Price Pullback",
"AMAT": "Sharp Recent Share Price Pullback",
"LFVN": "Promising Penny Stocks",
"ICLR": "Accounting Investigation Threatens 2025 Earnings",
"PL": "Strong Year Of Share Price Momentum",
"IMUX": "$400M raise to fund late-stage MS trials, commercial push",
"AGX": "13.7% Jump",
"VST": "Market Dips"
}